SCHEMBL7325309

SCHEMBL7325309

CC(=O)SCC(Cc1ccc(Cl)cc1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.49
EPHX2 P34913 1/20 0.49
KMT2A Q03164 2/20 0.46
PPARA Q07869 4/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
ABCC3 O15438 1/20 0.45
NR1I2 O75469 1/20 0.45
ABCB11 O95342 1/20 0.45
NR3C1 P04150 1/20 0.45
RARG P13631 1/20 0.45
CNR1 P21554 1/20 0.45
OPRK1 P41145 1/20 0.45
NR1H2 P55055 1/20 0.45
NR1H3 Q13133 1/20 0.45
NR1I3 Q14994 1/20 0.45
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7435690 0.86 CYP1A2 (0.46) PPARGPPARACYP1A2CYP3A4CYP2D6
SCHEMBL838961 0.85 CYP1A2 (0.63) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6154521 0.85 CYP1A2 (0.63) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL838962 0.85 CYP1A2 (0.63) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL400158 0.84 MME (0.54) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7435026 0.84 CYP1A2 (0.45) PPARGPPARACYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL6572923 0.84 CYP1A2 (0.61) PPARACYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL6572922 0.84 CYP1A2 (0.61) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7319468 0.83 CYP1A2 (0.51) PPARGPPARACYP1A2CYP3A4CYP2D6
SCHEMBL7428223 0.83 CYP1A2 (0.44) KMT2APPARACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0636621-B1 Beta-mercapto-propanamide derivatives useful in the treatment of cardiovascular diseases ZAMBON SPA (IT) 1997-03-12 EP disclosed
US-5506259-A β-mercapto-propanamide derivatives useful in the treatment of cardiovascular diseases ZAMBON GROUP S.P.A. (IT) 1996-04-09 US disclosed
EP-0636621-A1 Beta-mercapto-propanamide derivatives useful in the treatment of cardiovascular diseases ZAMBON GROUP S.p.A. (IT) 1995-02-01 EP disclosed
US-5262436-A Administering; enzyme inhibitor SCHERING CORPORATION (US) 1993-11-16 US disclosed
EP-0566157-A1 Neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1993-10-20 EP disclosed
US-5061710-A Atrial natriuretic factors SCHERING CORPORATION (US) 1991-10-29 US disclosed
US-4929641-A DIURETICS, ANGIOTENSIN CONVERTING ENZYMES SCHERING CORPORATION (US) 1990-05-29 US disclosed
US-4801609-A Mercapto-acylamino acid antihypertensives SCHERING CORPORATION (US) 1989-01-31 US disclosed
EP-0254032-A2 Neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1988-01-27 EP disclosed